After that, we further determined the TS expression level in gefitinib‐sensitive lung cancer cells (PC9 and HCC827) and the corresponding gefitinib‐resistant PC9/GR and HCC827/GR cells. This evidence concerns the gene TYMS and lung carcinoma.